Targeting early stages of cardiotoxicity from anti-PD1 immune checkpoint inhibitor therapy

Lars Michel; Iris Helfrich; Ulrike Barbara Hendgen-Cotta; Raluca-Ileana Mincu; Sebastian Korste; Simone Maria Mrotzek; Armin Spomer; Andrea Odersky; Christoph Rischpler; Ken Herrmann; Lale Umutlu; Cristina Coman; Robert Ahrends; Albert Sickmann; Stefanie Löffek; Elisabeth Livingstone; Selma Ugurel; Lisa Zimmer; Matthias Gunzer; Dirk Schadendorf; Matthias Totzeck; Tienush Rassaf

doi:10.1093/eurheartj/ehab430

Targeting early stages of cardiotoxicity from anti-PD1 immune checkpoint inhibitor therapy

Lars Michel, Iris Helfrich, Ulrike Barbara Hendgen-Cotta, Raluca-Ileana Mincu, Sebastian Korste, Simone Maria Mrotzek, Armin Spomer, Andrea Odersky, Christoph Rischpler, Ken Herrmann, Lale Umutlu, Cristina Coman, Robert Ahrends, Albert Sickmann, Stefanie Löffek, Elisabeth Livingstone, Selma Ugurel, Lisa Zimmer, Matthias Gunzer, Dirk SchadendorfMatthias Totzeck, Tienush Rassaf (Corresponding author)

Department of Analytical Chemistry

Publications: Contribution to journal › Article › Peer Reviewed

Original language	English
Pages (from-to)	316-329
Number of pages	15
Journal	European Heart Journal
Volume	43
Issue number	4
DOIs	https://doi.org/10.1093/eurheartj/ehab430
Publication status	Published - 21 Jan 2022

Austrian Fields of Science 2012

104002 Analytical chemistry
301305 Medical chemistry
302032 Cardiology

Keywords

CELL
Cardio-oncology
Cardiotoxicity
Immune checkpoint inhibitor
Inflammation
NECROSIS-FACTOR-ALPHA
Programmed death 1
Tumour necrosis factor alpha

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/eurheartj/ehab430

Cite this

Michel, L., Helfrich, I., Hendgen-Cotta, U. B., Mincu, R.-I., Korste, S., Mrotzek, S. M., Spomer, A., Odersky, A., Rischpler, C., Herrmann, K., Umutlu, L., Coman, C., Ahrends, R., Sickmann, A., Löffek, S., Livingstone, E., Ugurel, S., Zimmer, L., Gunzer, M., ... Rassaf, T. (2022). Targeting early stages of cardiotoxicity from anti-PD1 immune checkpoint inhibitor therapy. European Heart Journal, 43(4), 316-329. https://doi.org/10.1093/eurheartj/ehab430

@article{eb1837f0271643829c06eb301261500a,

title = "Targeting early stages of cardiotoxicity from anti-PD1 immune checkpoint inhibitor therapy",

keywords = "CELL, Cardio-oncology, Cardiotoxicity, Immune checkpoint inhibitor, Inflammation, NECROSIS-FACTOR-ALPHA, Programmed death 1, Tumour necrosis factor alpha",

author = "Lars Michel and Iris Helfrich and Hendgen-Cotta, {Ulrike Barbara} and Raluca-Ileana Mincu and Sebastian Korste and Mrotzek, {Simone Maria} and Armin Spomer and Andrea Odersky and Christoph Rischpler and Ken Herrmann and Lale Umutlu and Cristina Coman and Robert Ahrends and Albert Sickmann and Stefanie L{\"o}ffek and Elisabeth Livingstone and Selma Ugurel and Lisa Zimmer and Matthias Gunzer and Dirk Schadendorf and Matthias Totzeck and Tienush Rassaf",

year = "2022",

month = jan,

day = "21",

doi = "10.1093/eurheartj/ehab430",

language = "English",

volume = "43",

pages = "316--329",

journal = "European Heart Journal",

issn = "0195-668X",

publisher = "OXFORD UNIV PRESS INC",

number = "4",

}

Michel, L, Helfrich, I, Hendgen-Cotta, UB, Mincu, R-I, Korste, S, Mrotzek, SM, Spomer, A, Odersky, A, Rischpler, C, Herrmann, K, Umutlu, L, Coman, C , Ahrends, R, Sickmann, A, Löffek, S, Livingstone, E, Ugurel, S, Zimmer, L, Gunzer, M, Schadendorf, D, Totzeck, M & Rassaf, T 2022, 'Targeting early stages of cardiotoxicity from anti-PD1 immune checkpoint inhibitor therapy', European Heart Journal, vol. 43, no. 4, pp. 316-329. https://doi.org/10.1093/eurheartj/ehab430

TY - JOUR

T1 - Targeting early stages of cardiotoxicity from anti-PD1 immune checkpoint inhibitor therapy

AU - Michel, Lars

AU - Helfrich, Iris

AU - Hendgen-Cotta, Ulrike Barbara

AU - Mincu, Raluca-Ileana

AU - Korste, Sebastian

AU - Mrotzek, Simone Maria

AU - Spomer, Armin

AU - Odersky, Andrea

AU - Rischpler, Christoph

AU - Herrmann, Ken

AU - Umutlu, Lale

AU - Coman, Cristina

AU - Ahrends, Robert

AU - Sickmann, Albert

AU - Löffek, Stefanie

AU - Livingstone, Elisabeth

AU - Ugurel, Selma

AU - Zimmer, Lisa

AU - Gunzer, Matthias

AU - Schadendorf, Dirk

AU - Totzeck, Matthias

AU - Rassaf, Tienush

PY - 2022/1/21

Y1 - 2022/1/21

KW - CELL

KW - Cardio-oncology

KW - Cardiotoxicity

KW - Immune checkpoint inhibitor

KW - Inflammation

KW - NECROSIS-FACTOR-ALPHA

KW - Programmed death 1

KW - Tumour necrosis factor alpha

UR - http://www.scopus.com/inward/record.url?scp=85123969755&partnerID=8YFLogxK

U2 - 10.1093/eurheartj/ehab430

DO - 10.1093/eurheartj/ehab430

M3 - Article

C2 - 34389849

SN - 0195-668X

VL - 43

SP - 316

EP - 329

JO - European Heart Journal

JF - European Heart Journal

IS - 4

ER -

Targeting early stages of cardiotoxicity from anti-PD1 immune checkpoint inhibitor therapy

Austrian Fields of Science 2012

Keywords

UN SDGs

Access to Document

Other files and links

Cite this